James Kinley

James Kinley

Finansdirektör/CFO på GREY MATTERS HEALTH INC.

Förmögenhet: 199 887 $ per 2026-09-30

48 år
Health Technology
Commercial Services
Communications

Profil

James F.
Kinley
is Chief Financial Officer & Director at Medicure, Inc. since 2026, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. since 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Former roles include Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-08-17 381 492 ( 4,28 % ) 105 292 $ 2026-09-30
2026-04-02 47 100 ( 0,45 % ) 94 200 $ 2026-09-30
2025-05-05 56 500 ( 0,1 % ) 396 $ 2026-09-30

Aktiva positioner av James Kinley

FöretagPositionStart
GREY MATTERS HEALTH INC. Finansdirektör/CFO 2021-12-01
MEDICURE INC. Finansdirektör/CFO 2026-07-24
WAVERLEY PHARMA INC. Direktör/Styrelseledamot 2024-06-20
CYTOPHAGE TECHNOLOGIES LTD. Finansdirektör/CFO 2026-01-20
Algernon Neuroscience, Inc.
Finansdirektör/CFO -

Tidigare kända positioner av James Kinley

FöretagPositionSlut
MEDICURE INC. Finansdirektör/CFO 2021-05-15
Finansdirektör/CFO 2016-01-18
Företagsledare/Principal -
BELL MTS Företagsledare/Principal -
Se detaljerna i James Kinleys erfarenhet

James Kinleys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

41

Första gradens relationer

9

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag9

Commercial Services

Health Technology

Communications

Commercial Services

Consumer Services

Health Technology

Health Technology

Algernon Neuroscience, Inc.

Finance

  1. Börsen
  2. Insiders
  3. James Kinley